Logo image of BBBY

BED BATH & BEYOND INC (BBBY) Stock Fundamental Analysis

USA - NYSE:BBBY - US6903701018 - Common Stock

8.65 USD
-0.11 (-1.26%)
Last: 10/13/2025, 8:04:00 PM
8.44 USD
-0.21 (-2.43%)
Pre-Market: 10/14/2025, 8:37:17 AM
Fundamental Rating

2

Taking everything into account, BBBY scores 2 out of 10 in our fundamental rating. BBBY was compared to 120 industry peers in the Specialty Retail industry. BBBY may be in some trouble as it scores bad on both profitability and health. BBBY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BBBY has reported negative net income.
In the past year BBBY has reported a negative cash flow from operations.
In multiple years BBBY reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: BBBY reported negative operating cash flow in multiple years.
BBBY Yearly Net Income VS EBIT VS OCF VS FCFBBBY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

With a Return On Assets value of -56.28%, BBBY is not doing good in the industry: 94.17% of the companies in the same industry are doing better.
BBBY's Return On Equity of -153.98% is on the low side compared to the rest of the industry. BBBY is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
ROA -56.28%
ROE -153.98%
ROIC N/A
ROA(3y)-39%
ROA(5y)-15.57%
ROE(3y)-83.49%
ROE(5y)-37.9%
ROIC(3y)N/A
ROIC(5y)N/A
BBBY Yearly ROA, ROE, ROICBBBY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With a Gross Margin value of 23.10%, BBBY is not doing good in the industry: 76.67% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BBBY has remained more or less at the same level.
BBBY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y0.73%
BBBY Yearly Profit, Operating, Gross MarginsBBBY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

1

2. Health

2.1 Basic Checks

BBBY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BBBY has more shares outstanding
The number of shares outstanding for BBBY has been increased compared to 5 years ago.
The debt/assets ratio for BBBY is higher compared to a year ago.
BBBY Yearly Shares OutstandingBBBY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BBBY Yearly Total Debt VS Total AssetsBBBY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.09, we must say that BBBY is in the distress zone and has some risk of bankruptcy.
BBBY's Altman-Z score of 0.09 is on the low side compared to the rest of the industry. BBBY is outperformed by 80.00% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that BBBY is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.14, BBBY is in the better half of the industry, outperforming 65.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 0.09
ROIC/WACCN/A
WACC9.33%
BBBY Yearly LT Debt VS Equity VS FCFBBBY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.91 indicates that BBBY may have some problems paying its short term obligations.
BBBY has a worse Current ratio (0.91) than 78.33% of its industry peers.
BBBY has a Quick Ratio of 0.91. This is a bad value and indicates that BBBY is not financially healthy enough and could expect problems in meeting its short term obligations.
BBBY has a Quick ratio of 0.87. This is in the better half of the industry: BBBY outperforms 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.87
BBBY Yearly Current Assets VS Current LiabilitesBBBY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

BBBY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.89%, which is quite good.
Looking at the last year, BBBY shows a very negative growth in Revenue. The Revenue has decreased by -26.63% in the last year.
The Revenue has been decreasing by -0.56% on average over the past years.
EPS 1Y (TTM)16.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.34%
Revenue 1Y (TTM)-26.63%
Revenue growth 3Y-20.31%
Revenue growth 5Y-0.56%
Sales Q2Q%-29.1%

3.2 Future

The Earnings Per Share is expected to grow by 16.37% on average over the next years. This is quite good.
Based on estimates for the next years, BBBY will show a very strong growth in Revenue. The Revenue will grow by 28.03% on average per year.
EPS Next Y77.84%
EPS Next 2Y36.79%
EPS Next 3Y23.39%
EPS Next 5Y16.37%
Revenue Next Year-26.49%
Revenue Next 2Y-9.44%
Revenue Next 3Y-0.88%
Revenue Next 5Y28.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BBBY Yearly Revenue VS EstimatesBBBY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BBBY Yearly EPS VS EstimatesBBBY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BBBY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BBBY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BBBY Price Earnings VS Forward Price EarningsBBBY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BBBY Per share dataBBBY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as BBBY's earnings are expected to grow with 23.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.79%
EPS Next 3Y23.39%

More info and screens

0

5. Dividend

5.1 Amount

BBBY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BED BATH & BEYOND INC

NYSE:BBBY (10/13/2025, 8:04:00 PM)

Premarket: 8.44 -0.21 (-2.43%)

8.65

-0.11 (-1.26%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners64.09%
Inst Owner Change0%
Ins Owners1.57%
Ins Owner Change0%
Market Cap496.60M
Analysts75.38
Price Target11.12 (28.55%)
Short Float %9.68%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.86%
Min EPS beat(2)21.2%
Max EPS beat(2)46.52%
EPS beat(4)2
Avg EPS beat(4)-33.62%
Min EPS beat(4)-121.07%
Max EPS beat(4)46.52%
EPS beat(8)3
Avg EPS beat(8)-34.81%
EPS beat(12)6
Avg EPS beat(12)-36.04%
EPS beat(16)9
Avg EPS beat(16)-27.97%
Revenue beat(2)1
Avg Revenue beat(2)-5.28%
Min Revenue beat(2)-21.15%
Max Revenue beat(2)10.58%
Revenue beat(4)1
Avg Revenue beat(4)-8.17%
Min Revenue beat(4)-21.15%
Max Revenue beat(4)10.58%
Revenue beat(8)3
Avg Revenue beat(8)-4.11%
Revenue beat(12)5
Avg Revenue beat(12)-3.62%
Revenue beat(16)6
Avg Revenue beat(16)0.87%
PT rev (1m)401.15%
PT rev (3m)401.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-171%
EPS NY rev (1m)0%
EPS NY rev (3m)68%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-73.02%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-78.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.44
P/FCF N/A
P/OCF N/A
P/B 3.79
P/tB 5.39
EV/EBITDA N/A
EPS(TTM)-3.64
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-1.97
FCFYN/A
OCF(TTM)-1.72
OCFYN/A
SpS19.66
BVpS2.28
TBVpS1.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.28%
ROE -153.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.1%
FCFM N/A
ROA(3y)-39%
ROA(5y)-15.57%
ROE(3y)-83.49%
ROE(5y)-37.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y0.73%
F-Score5
Asset Turnover3.15
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.64%
Cap/Sales 1.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.87
Altman-Z 0.09
F-Score5
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)142.46%
Cap/Depr(5y)112.5%
Cap/Sales(3y)1.7%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.34%
EPS Next Y77.84%
EPS Next 2Y36.79%
EPS Next 3Y23.39%
EPS Next 5Y16.37%
Revenue 1Y (TTM)-26.63%
Revenue growth 3Y-20.31%
Revenue growth 5Y-0.56%
Sales Q2Q%-29.1%
Revenue Next Year-26.49%
Revenue Next 2Y-9.44%
Revenue Next 3Y-0.88%
Revenue Next 5Y28.03%
EBIT growth 1Y39.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year78.56%
EBIT Next 3Y26.6%
EBIT Next 5Y28.87%
FCF growth 1Y-92.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-534.55%
OCF growth 3YN/A
OCF growth 5YN/A